A Speedinvest portfolio company


Year Invested
Diagnosia helps health professionals make better decisions by providing a search engine of drug information.

Diagnosia (acquired by Mediately in 2022) is a mobile and web-based app, which helps doctors and other healthcare professionals make the right medication decision. Additionally, the platform serves as a highly-targeted marketing channel for pharmaceutical companies interested in advertising on the platform.

Diagnosia was founded in 2011 by a group of medical doctors, software engineers, and entrepreneurs. Over the years the company has established itself as the market leader for clinical drug information software in Austria with more than 5,000 health professionals and over 50 healthcare facilities using their app.

Hi, we're Speedinvest

Proud partners with Europe's most visionary founders who are redefining technology's role in our daily lives.

Tell us about your startup